AHA Basic Cardiovascular Sciences OnDemand 2026 focuses on the mechanisms behind cardiovascular disease and the research tools used to investigate them. The program spans sarcomere function, cardiac remodeling, fibrosis, metabolism, immune signaling and congenital heart disease, alongside tissue engineering and emerging translational technologies. It also includes early-career scientific sessions. The original meeting took place July 13–16, 2026, at the Sheraton Boston under the theme “Shaping the Future of Cardiovascular Medicine: Integrating Basic Science Breakthroughs to Clinical Impact.” This material is most relevant to cardiovascular researchers, clinician-scientists, fellows and trainees seeking a research-focused update rather than a general clinical cardiology review.
Topics
-
BCVS 2026 Closing Remarks
-
BCVS 2026 Keynote Lecture
-
Cardiac Cellular Signaling Mechanisms and Cross talk
-
Cardiac Growth Hypertrophy and Remodeling
-
Cardiac Repair Biomaterials and Tissue Engineering
-
Cardiac Sarcomeres and Myofilaments
-
Cardio-Immunology Inflammation Immunity and the Heart
-
Cardiovascular Development Gene Regulation and Congenital Heart Disease
-
Early Career Keynote
-
Early Career Pre-Conference Opening Welcome
-
Early Career Pre-Conference Session 1 Next Best Thing
-
Early Career Pre-Conference Session 2 Next Best Thing
-
Emerging Cardiovascular Translational Technologies
-
Molecular Targets for Heart Failure and Cardiomyopathy
-
Outstanding Early Career Investigator Award
-
Pathophysiologic and Systemic Axes Beyond the Heart
-
The Age of Metabolism
-
Unlocking New Mechanisms in Cardiac Arrhythmia
-
Whats New in Cardiovascular Fibrosis
The source describes the official OnDemand release, launched July 18, 2026, as offering 15+ sessions. This is not a verified count of store files. Official AHA search, captions, summaries, bookmarking and note-taking features are platform services and are not established as part of this package. The 17-credit designation applied to the original live activity; BCVS OnDemand 2026 is described as carrying no CE/CME credit.



